Future directions
Future work will focus on comparison of prospectively acquired KBR and
3DE datasets, to further validate the Ventripoint KBR platform and VMS+
3.0 software as alternatives to atrial and ventricular volumes measured
using MRI and 3DE. The availability of multiple validated analysis
packages will encourage work in pediatric echocardiography that assesses
3DE volumetrics assessment as a prognostic and treatment indicator and
may lead to inclusion of these parameters in future echocardiographic
guidelines to aid in clinical decision making.